🇺🇸 FDA
Patent

US 8685926

Compositions and method for CaMKII inhibitors and uses thereof

granted A61KA61K38/00A61P

Quick answer

US patent 8685926 (Compositions and method for CaMKII inhibitors and uses thereof) held by The Regents of the University of Colorado, a Body Corporate expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61P, A61P25/00, A61P25/16